Join us:
January 10–12, 2022 in-person in San FranciscoJanuary 17–19, 2022 virtually

Rich Horgan
Founder at Cure Rare Disease


Rich Horgan is the Founder and President of Cure Rare Disease. He has a deep passion for Duchenne muscular dystrophy (DMD) and other rare diseases. With a younger brother impacted by DMD, Rich has a strong interest in accelerating promising treatments for the disease. He has formed a collaboration with world-class researchers and clinicians to pioneer the rapid development of customized therapies for Duchenne and other rare diseases. Rich holds a BS from Cornell University where he graduated summa cum laude, and an MBA from Harvard Business School where he was awarded the Blavatnik Fellowship for Life Science Entrepreneurship.

Agenda Sessions

  • OPEN SESSION - From de-risking to value creation – The evolving role of patient communities in rare disease drug development and commercialization

    On Demand

Speakers at this event